Navigation Links
Surgex(TM) Fuels 2008 San Luis Potosi Open Champion Russell Surber Through Grueling 36 Hole Final Day
Date:5/28/2008

Wins First Canadian Golf Tour Title While Wearing Surgex(TM) Branded

Apparel

BASKING RIDGE, N.J., May 28 /PRNewswire-FirstCall/ -- Russell Surber overcame a virus and a late bogey to capture his first Canadian Tour title at the San Luis Potosi Open by two strokes over Adam Bland and Wil Collins. The victory places the former University of Texas standout in prime position to qualify for the PGA's RBC Canadian Open held in July. An avid strength and conditioning advocate, Surber relies on Surgex(TM) sports nutritional formula to help accelerate his recovery from workouts and long hours on the course.

Surber stated, "Drinking Surgex(TM) leading up to and through this week's tournament definitely helped me fight through a challenging final 36 holes. Strength and endurance training has become an integral part of my tournament preparations and using Surgex(TM) this season has helped my golf game tremendously."

Surber's decision to train with Surgex(TM) is another example of the growing trend amongst many professional athletes and teams using Millennium's clinically validated sports drink to assist in their strength and recovery. Russell will look to keep his stellar play going when he competes in this week's Spring Qualifying School in British Columbia, Vancouver. Many of today's well known players including Chris DiMarco, Tim Herron and Mike Weir used this prominent event to springboard themselves to very successful careers on the PGA Tour.

About SURGEX(TM):

SURGEX(TM) (http://www.surgexsports.com) was created from Millennium's extensive experience providing advanced nutritional formulas to some of the most prestigious medical institutions throughout the United States. The proprietary SURGEX(TM) formula intends to meet the growing demand of professional, amateur, and Olympic athletes as well as their coaches looking for nutritional support in a marketplace dominated by products with no clinical proof of benefit, unsubstantiated claims, excess protein, stimulants, and banned substances.

In double blind placebo controlled clinical trials conducted at the Rutgers University Human Performance Lab SURGEX(TM) significantly outperformed leading competitive products by assisting in reducing the damaging effects of exercise. SURGEX(TM) proved to be a superior product by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as reducing free radical production (oxidative stress). The formula meets NCAA guidelines for use by collegiate athletes and is certified by The Banned Substances Control Group (BSCG) to contain no banned substances.

Statements in this news release regarding future financial and operating results, future growth in R&D programs, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward- looking statements including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of the Company's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including Forms 10-KSB, 10-QSB, 8-K, and other forms filed with the Securities and Exchange Commission ("SEC"). These statements have not been evaluated by the Food and Drug Administration. SURGEX(TM) is not intended to diagnose, treat, cure, or prevent and disease.

Contact: John Swon, 908-604-2500


'/>"/>
SOURCE Millennium Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SURGEX(TM) Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard
2. Calorie restriction inhibits, obesity fuels development of epithelial cancers
3. Calorie restriction limits Calorie restriction inhibits, obesity fuels development of epithelial can
4. Calorie restriction limits and obesity fuels development of epithelial cancers
5. CompareNetworks, Inc. Fuels Growth by Raising Round of Financing
6. Researchers identify and shut down protein that fuels ovarian cancer
7. NexGen Biofuels Ltd Announces the Change of its Symbol to "NXGN"
8. Medicare Drug Plan Fuels Health-Care Spending
9. OHSU Cancer Institute researcher discovers what fuels certain cancer mutation
10. Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction
11. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... of enhancements, upgrading their training and leads programs. , In February, 2017, Empower ... elite sales agents, Performance Partners is designed to teach how to maximize their ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming ... the creation of published author, Wesley Gerboth, a World War II veteran, with a ... Now, at age ninety-one, he shares the Wisdom God bestowed upon him in this ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, ... and silly dog who lives his life to the fullest, as God intended. “The ... author Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially about ...
(Date:3/23/2017)... ... , ... The physicians of KSF Orthopaedic Center PA are proud to announce ... is located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 inside ... patients living in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) with ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Convention Center at 10 North Broadway Avenue, will be an educational and exciting ... practical instruction in the management of chronic pain. , Oklahoma is in a ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
(Date:3/24/2017)... , Mar 24, 2017 The Board ... the company,s Annual Report 2016 including the complete 2016 Annual ... and available on Nordic Nanovector,s website in the section Investor ... ... IR enquiries: Tone Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ...
(Date:3/23/2017)... PUNE, India , March 23, 2017 ... are growing ageing population, increasing diabetic population, accelerating economic growth ... developments of this industry are higher life expectancy of ESRD ... potential in emerging markets. However, the expansion of the market ... ...
Breaking Medicine Technology: